Abbott Laboratories (ABT)

$84.35 +1.79 (2.17%)
Market Cap 143.80B
Revenue (ttm) 44.33B
Net Income (ttm) 6.52B
EPS (ttm) N/A
PE Ratio 16.18
Forward PE 15.40
Profit Margin 14.72%
Debt to Equity Ratio 0.65
Volume 16,392,500
Avg Vol 12,791,210
Day's Range N/A - N/A
Shares Out 1.74B
Stochastic %K 25%
Beta 0.65
Analysts Strong Sell
Price Target $119.00

Company Profile

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement ther...

Industry: Medical Devices
Sector: Healthcare
Phone: 224 667 6100
Address:
100 Abbott Park Road, Abbott Park, United States
serier
serier May. 13 at 2:19 PM
$ABT disappointed. Will hold for the moment and average down if it falls more.
0 · Reply
marketbeater80
marketbeater80 May. 13 at 1:42 PM
$ABT absolute dog of a stock. Wow. Filled yesterday's gap like it was nothing. Close is what matters though.
0 · Reply
Stocktwits1987
Stocktwits1987 May. 13 at 1:42 PM
$ABT P/E is still high.
0 · Reply
serier
serier May. 13 at 1:41 PM
$ABT -15k in my portfolio every day. WTF.
0 · Reply
Probably_Drunk
Probably_Drunk May. 13 at 1:39 PM
$ABT The idea of this having more than 1 small geeen day after weeks of red is asking too much
0 · Reply
serier
serier May. 13 at 1:38 PM
$ABT fuck the stock market.
0 · Reply
Pharmer23
Pharmer23 May. 13 at 12:41 PM
$ABT safest place to put your money right now . Irrational sell off is an opportunity in this hyped up market .
0 · Reply
Probably_Drunk
Probably_Drunk May. 13 at 2:23 AM
$ABT AI is back at it overnight again. Whod a thunk it. Looks like this was a 1 day fluke being green. Nobody wants value when you can make 80% returns in 2 weeks on DRAM 🤷‍♂️ 🤷‍♂️ 🤷‍♂️ Never ending demand and never ending spend. Everyone wins in AI
1 · Reply
john565
john565 May. 12 at 8:56 PM
$ABT I forgot that green days exist here.. Holding strong
0 · Reply
Togdjclecj
Togdjclecj May. 12 at 8:05 PM
$ABT green is green. Now lets get some damn continuation!
1 · Reply
Latest News on ABT
Jefferies medical supplies analyst holds analyst/industry conference call

2026-05-07T22:44:28.000Z - 5 days ago

Jefferies medical supplies analyst holds analyst/industry conference call

Abbott removed from US Conviction List at Goldman Sachs

2026-05-01T09:21:21.000Z - 12 days ago

Abbott removed from US Conviction List at Goldman Sachs

Abbott receives FDA clearance and CE Mark for Ultreon imaging platform

2026-04-28T13:41:07.000Z - 15 days ago

Abbott receives FDA clearance and CE Mark for Ultreon imaging platform

Abbott receives FDA clearance and CE Mark for next-generation Ultreon™ 3.0 AI-powered coronary imaging platform

Apr 28, 2026, 9:00 AM EDT - 15 days ago

Abbott receives FDA clearance and CE Mark for next-generation Ultreon™ 3.0 AI-powered coronary imaging platform

Abbott announces new late-breaking data from four trials on PFA, CSP portfolios

2026-04-26T17:40:08.000Z - 16 days ago

Abbott announces new late-breaking data from four trials on PFA, CSP portfolios

Abbott showcases strength of its technologies to address abnormal heart rhythms with late-breaking clinical data at Heart Rhythm Society 2026

Apr 25, 2026, 12:30 PM EDT - 17 days ago

Abbott showcases strength of its technologies to address abnormal heart rhythms with late-breaking clinical data at Heart Rhythm Society 2026

3 ‘Strong Buy’ Dividend Aristocrat Stocks, 4/23/26

2026-04-23T22:27:18.000Z - 19 days ago

3 ‘Strong Buy’ Dividend Aristocrat Stocks, 4/23/26

CTAS CVX

New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test

Apr 17, 2026, 3:30 PM EDT - 25 days ago

New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test

Abbott Laboratories Cuts Outlook, Says Mild Flu Season Hurt Sales

Apr 16, 2026, 11:22 AM EDT - 26 days ago

Abbott Laboratories Cuts Outlook, Says Mild Flu Season Hurt Sales

Abbott Laboratories Earnings Call Transcript: Q1 2026

Apr 16, 2026, 9:00 AM EDT - 27 days ago

Abbott Laboratories Earnings Call Transcript: Q1 2026

Abbott Stock Tumbles on Earnings. Nutrition Business Is Struggling and Merger Costs Are Biting.

Apr 16, 2026, 8:05 AM EDT - 27 days ago

Abbott Stock Tumbles on Earnings. Nutrition Business Is Struggling and Merger Costs Are Biting.

Abbott first-quarter results beat on cancer diagnostics, medical device strength

Apr 16, 2026, 7:33 AM EDT - 27 days ago

Abbott first-quarter results beat on cancer diagnostics, medical device strength

Abbott Reports First-Quarter 2026 Results; Updates Guidance to Reflect Acquisition of Exact Sciences

Apr 16, 2026, 7:30 AM EDT - 27 days ago

Abbott Reports First-Quarter 2026 Results; Updates Guidance to Reflect Acquisition of Exact Sciences

Jury orders Abbott to pay $53 million in preterm infant formula trial, media report says

Apr 9, 2026, 10:16 PM EDT - 4 weeks ago

Jury orders Abbott to pay $53 million in preterm infant formula trial, media report says

New survey finds most Americans believe chronic diseases are preventable, but only 1 in 4 feel confident in how to care for their health

Apr 9, 2026, 9:00 AM EDT - 4 weeks ago

New survey finds most Americans believe chronic diseases are preventable, but only 1 in 4 feel confident in how to care for their health

Abbott expands access to Precision Oncology portfolio through integration with Flatiron's OncoEMR® platform

Mar 30, 2026, 9:00 AM EDT - 6 weeks ago

Abbott expands access to Precision Oncology portfolio through integration with Flatiron's OncoEMR® platform

Abbott hosts conference call for first-quarter earnings

Mar 26, 2026, 9:00 AM EDT - 6 weeks ago

Abbott hosts conference call for first-quarter earnings

John Stamos and Jodie Sweetin reunite for "The (Second) Talk" with Cologuard® tests, encouraging colon cancer screening

Mar 24, 2026, 8:00 AM EDT - 7 weeks ago

John Stamos and Jodie Sweetin reunite for "The (Second) Talk" with Cologuard® tests, encouraging colon cancer screening

Abbott completes acquisition of Exact Sciences

Mar 23, 2026, 8:50 AM EDT - 7 weeks ago

Abbott completes acquisition of Exact Sciences

Abbott acquisition of Exact Sciences set to close on March 23, 2026

Mar 20, 2026, 9:00 AM EDT - 7 weeks ago

Abbott acquisition of Exact Sciences set to close on March 23, 2026

Pivot Bio CEO Chris Abbott to Present at World Agri-Tech Innovation Summit

Mar 13, 2026, 2:17 PM EDT - 2 months ago

Pivot Bio CEO Chris Abbott to Present at World Agri-Tech Innovation Summit

Landmark study shows Libre technology helps people with Type 2 diabetes on basal insulin improve glucose management

Mar 12, 2026, 8:00 AM EDT - 2 months ago

Landmark study shows Libre technology helps people with Type 2 diabetes on basal insulin improve glucose management

Exact Sciences Stockholders Approve Acquisition by Abbott

Feb 20, 2026, 4:05 PM EST - 2 months ago

Exact Sciences Stockholders Approve Acquisition by Abbott

EXAS

Abbott declares 409th consecutive quarterly dividend

Feb 20, 2026, 11:38 AM EST - 2 months ago

Abbott declares 409th consecutive quarterly dividend

Carl Abbott's “House of Columns” Brings Sarasota School Modernism to the Market on Longboat Key

Feb 17, 2026, 11:32 AM EST - 3 months ago

Carl Abbott's “House of Columns” Brings Sarasota School Modernism to the Market on Longboat Key

These 32 favorite stocks signal the bull market is running on fumes

Feb 12, 2026, 8:05 AM EST - 3 months ago

These 32 favorite stocks signal the bull market is running on fumes

AAPL ADBE AMGN AVGO BAC BK BMY

Late-breaking data presentations showcase the safety and efficacy of Abbott's ablation catheters to treat people with atrial fibrillation

Feb 6, 2026, 8:00 AM EST - 3 months ago

Late-breaking data presentations showcase the safety and efficacy of Abbott's ablation catheters to treat people with atrial fibrillation

Abbott recalls glucose sensors after seven deaths linked to faulty readings

Feb 4, 2026, 10:49 AM EST - 3 months ago

Abbott recalls glucose sensors after seven deaths linked to faulty readings

Is The Fall In Abbott Stock Justified?

Jan 23, 2026, 9:35 AM EST - 3 months ago

Is The Fall In Abbott Stock Justified?

Abbott faces India scrutiny in cough syrup abuse investigation, documents show

Jan 23, 2026, 6:43 AM EST - 3 months ago

Abbott faces India scrutiny in cough syrup abuse investigation, documents show

Abbott Laboratories Raised Prices, Prompting Sales Slump

Jan 22, 2026, 2:31 PM EST - 3 months ago

Abbott Laboratories Raised Prices, Prompting Sales Slump

MRNA Rallies on Cancer Vaccine Trial, PG Mixed Earnings, ABT Sell-Off

Jan 22, 2026, 11:00 AM EST - 3 months ago

MRNA Rallies on Cancer Vaccine Trial, PG Mixed Earnings, ABT Sell-Off

MRNA PG

Cramer's Mad Dash: Abbott Labs

Jan 22, 2026, 9:53 AM EST - 3 months ago

Cramer's Mad Dash: Abbott Labs

Abbott Laboratories Earnings Call Transcript: Q4 2025

Jan 22, 2026, 9:00 AM EST - 3 months ago

Abbott Laboratories Earnings Call Transcript: Q4 2025

Abbott Stock Slumps on Earnings. What's Weighing on the Medical Devices Maker.

Jan 22, 2026, 7:49 AM EST - 3 months ago

Abbott Stock Slumps on Earnings. What's Weighing on the Medical Devices Maker.

Abbott misses quarterly revenue estimates on weakness in diagnostics segment

Jan 22, 2026, 7:34 AM EST - 3 months ago

Abbott misses quarterly revenue estimates on weakness in diagnostics segment

Abbott Reports Fourth-Quarter and Full-Year 2025 Results; Issues 2026 Financial Outlook

Jan 22, 2026, 7:30 AM EST - 3 months ago

Abbott Reports Fourth-Quarter and Full-Year 2025 Results; Issues 2026 Financial Outlook

Abbott receives CE Mark for the TactiFlex™ Duo Ablation Catheter to treat patients with abnormal heart rhythms

Jan 20, 2026, 9:00 AM EST - 4 months ago

Abbott receives CE Mark for the TactiFlex™ Duo Ablation Catheter to treat patients with abnormal heart rhythms

Sentinel Opportunity Fund I Closes Seventh and Eighth Acquisitions with Abbott Laboratories and V3 Engineering, Advancing a Diversified Portfolio Strategy

Jan 7, 2026, 8:00 AM EST - 4 months ago

Sentinel Opportunity Fund I Closes Seventh and Eighth Acquisitions with Abbott Laboratories and V3 Engineering, Advancing a Diversified Portfolio Strategy

Abbott hosts conference call for fourth-quarter earnings

Jan 5, 2026, 4:30 PM EST - 4 months ago

Abbott hosts conference call for fourth-quarter earnings

Abbott's new Libre Assist app feature tackles a top need for people living with diabetes: in-the-moment food decisions

Jan 5, 2026, 9:05 AM EST - 4 months ago

Abbott's new Libre Assist app feature tackles a top need for people living with diabetes: in-the-moment food decisions

Abbott's Volt™ Pulsed Field Ablation System Receives FDA Approval to Treat Patients with Atrial Fibrillation

Dec 22, 2025, 9:00 AM EST - 5 months ago

Abbott's Volt™ Pulsed Field Ablation System Receives FDA Approval to Treat Patients with Atrial Fibrillation

Abbott's Amplatzer Piccolo™ Delivery System Receives FDA Clearance and CE Mark to Optimize Procedures for Premature Babies With a Hole in the Heart

Dec 18, 2025, 9:00 AM EST - 5 months ago

Abbott's Amplatzer Piccolo™ Delivery System Receives FDA Clearance and CE Mark to Optimize Procedures for Premature Babies With a Hole in the Heart

Abbott increases quarterly dividend for 54th consecutive year

Dec 12, 2025, 10:26 AM EST - 5 months ago

Abbott increases quarterly dividend for 54th consecutive year

Abbott's Lingo™ Now on Android™, Expanding Access to Real-Time Glucose Data

Dec 8, 2025, 9:00 AM EST - 5 months ago

Abbott's Lingo™ Now on Android™, Expanding Access to Real-Time Glucose Data

University of Wisconsin Wins Abbott and Big Ten's 'We Give Blood' Competition as Campaign Donations Surge 319%, Helping Save Nearly 250,000 Lives

Dec 6, 2025, 8:45 PM EST - 5 months ago

University of Wisconsin Wins Abbott and Big Ten's 'We Give Blood' Competition as Campaign Donations Surge 319%, Helping Save Nearly 250,000 Lives

Muscles, the New Flex: Abbott Launches Two New Ensure® Max Protein Shakes to Tap into Growing Muscle Health Movement

Dec 4, 2025, 11:00 AM EST - 5 months ago

Muscles, the New Flex: Abbott Launches Two New Ensure® Max Protein Shakes to Tap into Growing Muscle Health Movement

Abbott issues US device correction for some glucose monitors over faulty readings risk

Nov 24, 2025, 11:08 AM EST - 6 months ago

Abbott issues US device correction for some glucose monitors over faulty readings risk

Exact Sciences Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Exact Sciences Corporation - EXAS

Nov 21, 2025, 8:30 PM EST - 6 months ago

Exact Sciences Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Exact Sciences Corporation - EXAS

EXAS

Abbott Laboratories Transcript: M&A Announcement

Nov 20, 2025, 9:00 AM EST - 6 months ago

Abbott Laboratories Transcript: M&A Announcement

Why Abbott is paying $21 billion for Exact Sciences and its Cologuard cancer test

Nov 20, 2025, 8:43 AM EST - 6 months ago

Why Abbott is paying $21 billion for Exact Sciences and its Cologuard cancer test

EXAS

Abbott to Acquire Exact Sciences for $21 Billion

Nov 20, 2025, 7:46 AM EST - 6 months ago

Abbott to Acquire Exact Sciences for $21 Billion

EXAS

Exact Sciences Stock Soars. Abbott Is Buying It in Deal Valued at $21 Billion.

Nov 20, 2025, 7:46 AM EST - 6 months ago

Exact Sciences Stock Soars. Abbott Is Buying It in Deal Valued at $21 Billion.

EXAS

Abbott bolsters diagnostics portfolio with up to $23 billion buyout of Exact Sciences

Nov 20, 2025, 7:36 AM EST - 6 months ago

Abbott bolsters diagnostics portfolio with up to $23 billion buyout of Exact Sciences

EXAS

Abbott to acquire Exact Sciences, a leader in large and fast-growing cancer screening and precision oncology diagnostics segments

Nov 20, 2025, 7:30 AM EST - 6 months ago

Abbott to acquire Exact Sciences, a leader in large and fast-growing cancer screening and precision oncology diagnostics segments

EXAS

Exact Sciences Stock Jumps on Reported Deal Interest From Abbott Laboratories

Nov 19, 2025, 4:27 PM EST - 6 months ago

Exact Sciences Stock Jumps on Reported Deal Interest From Abbott Laboratories

EXAS

Abbott is weighing takeover of Exact Sciences, Bloomberg News reports

Nov 19, 2025, 1:50 PM EST - 6 months ago

Abbott is weighing takeover of Exact Sciences, Bloomberg News reports

EXAS

serier
serier May. 13 at 2:19 PM
$ABT disappointed. Will hold for the moment and average down if it falls more.
0 · Reply
marketbeater80
marketbeater80 May. 13 at 1:42 PM
$ABT absolute dog of a stock. Wow. Filled yesterday's gap like it was nothing. Close is what matters though.
0 · Reply
Stocktwits1987
Stocktwits1987 May. 13 at 1:42 PM
$ABT P/E is still high.
0 · Reply
serier
serier May. 13 at 1:41 PM
$ABT -15k in my portfolio every day. WTF.
0 · Reply
Probably_Drunk
Probably_Drunk May. 13 at 1:39 PM
$ABT The idea of this having more than 1 small geeen day after weeks of red is asking too much
0 · Reply
serier
serier May. 13 at 1:38 PM
$ABT fuck the stock market.
0 · Reply
Pharmer23
Pharmer23 May. 13 at 12:41 PM
$ABT safest place to put your money right now . Irrational sell off is an opportunity in this hyped up market .
0 · Reply
Probably_Drunk
Probably_Drunk May. 13 at 2:23 AM
$ABT AI is back at it overnight again. Whod a thunk it. Looks like this was a 1 day fluke being green. Nobody wants value when you can make 80% returns in 2 weeks on DRAM 🤷‍♂️ 🤷‍♂️ 🤷‍♂️ Never ending demand and never ending spend. Everyone wins in AI
1 · Reply
john565
john565 May. 12 at 8:56 PM
$ABT I forgot that green days exist here.. Holding strong
0 · Reply
Togdjclecj
Togdjclecj May. 12 at 8:05 PM
$ABT green is green. Now lets get some damn continuation!
1 · Reply
serier
serier May. 12 at 7:53 PM
$ABT pathetic.
0 · Reply
Loudermilk64
Loudermilk64 May. 12 at 6:24 PM
$ABT I just have a feeling I’m already wishing I’d bought more of this nose bleeeders instead of stressing. 😂
0 · Reply
Iam4our
Iam4our May. 12 at 6:00 PM
$ABT Might be a bounce after ER..
1 · Reply
Probably_Drunk
Probably_Drunk May. 12 at 5:20 PM
$ABT Degens cant handle even 1 red day in the AI names. Smh
1 · Reply
serier
serier May. 12 at 5:13 PM
$ADBE to the hell. Sold all for $ABT
0 · Reply
Loudermilk64
Loudermilk64 May. 12 at 4:41 PM
$ABT I wonder if it’s turned?
1 · Reply
Loudermilk64
Loudermilk64 May. 12 at 3:09 PM
$ABT Weird how its up all of a sudden on a red day?
3 · Reply
dddanielek
dddanielek May. 12 at 3:06 PM
$ABT MM must be on lunch taking a break from shorting
0 · Reply
STOCKPICKERTRADER
STOCKPICKERTRADER May. 12 at 3:06 PM
$BSX sector rotation helping here $IHI $MDT $ABT $DHR
0 · Reply
Enjoy_Life_Bro
Enjoy_Life_Bro May. 12 at 2:33 PM
$ABT Trap
0 · Reply
Loudermilk64
Loudermilk64 May. 12 at 2:28 PM
$ABT I think it’s going down to 75 like Netflix did.
0 · Reply
Probably_Drunk
Probably_Drunk May. 12 at 2:19 PM
$ABT Down 33% year to date and on the 11th week in a row of red and struggling to hold a 1% gain today with market momentum names taking a breather. Man i know how to pick the winners for sure. Sign up for my discord guys. Only 1,999.99 a month. Help me recoup my losses here
2 · Reply